Should hypoxia preconditioning become the standardized procedure for bone marrow MSCs preparation for clinical use?
Shenzhen Engineering Laboratory of Orthopaedic Regenerative Technologies, Orthopaedic Research Center, Peking University Shenzhen Hospital, Shenzhen, P.R.China.
Yong-Can
YC
Huang
Centro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy.
Ornella
O
Parolini
Laboratory of Stem Cell and Tissue Engineering, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P. R. China.
Li
L
Deng
Shenzhen Engineering Laboratory of Orthopaedic Regenerative Technologies, Orthopaedic Research Center, Peking University Shenzhen Hospital, Shenzhen, P.R.China.|Shenzhen Key Laboratory of Spine Surgery, Department of Spine Surgery, Peking University Shenzhen Hospital, Shenzhen, P.R.China.
Bin-Sheng
BS
Yu
D001854:Bone Marrow Cells / Q000166:cytology / Q000378:metabolism*; D015687:Cell Hypoxia / Q000502:physiology; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000378:metabolism*
Bone marrow; Genomics; Hypoxia; Mesenchymal stem cells